Current Radiotherapy Considerations for Nasopharyngeal Carcinoma

被引:26
|
作者
Ng, Wai Tong [1 ,2 ,3 ]
Chow, James C. H. [4 ]
Beitler, Jonathan J. [5 ]
Corry, June [6 ]
Mendenhall, William [7 ]
Lee, Anne W. M. [1 ,2 ]
Robbins, K. Thomas [8 ]
Nuyts, Sandra [9 ]
Saba, Nabil F. [10 ]
Smee, Robert [11 ]
Stokes, William A. [12 ]
Strojan, Primoz [13 ]
Ferlito, Alfio
机构
[1] Univ Hong Kong, Shenzhen Hosp, Clin Oncol Ctr, Shenzhen 518009, Peoples R China
[2] Univ Hong Kong, Shenzhen Hosp, Shenzhen Key Lab Canc Metastasis & Personalized Th, Shenzhen 518009, Peoples R China
[3] Univ Hong Kong, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Peoples R China
[4] Queen Elizabeth Hosp, Dept Clin Oncol, Hong Kong, Peoples R China
[5] Knox Cty Hlth Clin, Rockland, ME 04841 USA
[6] St Vincents Hosp, Div Radiat Oncol, GenesisCare Radiat Oncol, Melbourne, Vic 3065, Australia
[7] Univ Florida, Dept Radiat Oncol, Coll Med, Gainesville, FL 32610 USA
[8] Southern Illinois Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Springfield, IL 62794 USA
[9] Univ Leuven, KU Leuven, Univ Hosp Leuven, Dept Radiat Oncol, B-3000 Leuven, Belgium
[10] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA
[11] Prince Wales Canc Ctr, Dept Radiat Oncol, Sydney, NSW 2031, Australia
[12] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Sch Med, Atlanta, GA 30322 USA
[13] Inst Oncol, Dept Radiat Oncol, Ljubljana 1000, Slovenia
关键词
nasopharyngeal cancer; radiotherapy; target delineation; adaptive planning; artificial intelligence; particle therapy; INTENSITY-MODULATED RADIOTHERAPY; CLINICAL TARGET VOLUME; LYMPH-NODE DISTRIBUTION; QUALITY-OF-LIFE; RADIATION-THERAPY; ARTIFICIAL-INTELLIGENCE; INDUCTION CHEMOTHERAPY; TREATMENT OUTCOMES; PROTON THERAPY; NCIC CTG;
D O I
10.3390/cancers14235773
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Nasopharyngeal carcinoma (NPC) is commonly treated using high-dose radiotherapy. Careful radiotherapy planning is crucial for the eradication of cancer cells while avoiding injuries to normal structures. This balance is often delicate given the complex anatomic location in which NPC is situated. This article highlights the considerations, practical pearls, and recent advances in the precise delivery of radiotherapy in NPC patients. Radiotherapy is the primary treatment modality for nasopharyngeal carcinoma (NPC). Successful curative treatment requires optimal radiotherapy planning and precise beam delivery that maximizes locoregional control while minimizing treatment-related side effects. In this article, we highlight considerations in target delineation, radiation dose, and the adoption of technological advances with the aim of optimizing the benefits of radiotherapy in NPC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Bossi, P.
    Chan, A. T.
    Licitra, L.
    Trama, A.
    Orlandi, E.
    Hui, E. P.
    Halamkova, J.
    Mattheis, S.
    Baujat, B.
    Hardillo, J.
    Smeele, L.
    van Herpen, C.
    Castro, A.
    Machiels, J-P
    ANNALS OF ONCOLOGY, 2021, 32 (04) : 452 - 465
  • [42] Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma
    Chan, Jason W.
    Parvathaneni, Upendra
    Yom, Sue S.
    FUTURE ONCOLOGY, 2017, 13 (05) : 425 - 431
  • [43] Clinical treatment considerations in the intensity-modulated radiotherapy era for parotid lymph node metastasis in patients with nasopharyngeal carcinoma
    Lin, Chao
    Lu, Nian
    Liang, Jiong-Lin
    Guo, Jia
    Gu, Li-Wen
    Sun, Rui
    Guo, Ling
    Yang, Qi
    RADIOTHERAPY AND ONCOLOGY, 2023, 186
  • [44] Combinations of radiotherapy with immunotherapy in nasopharyngeal carcinoma
    Yang, Xiaojing
    Ren, Hanru
    Li, Zhen
    Peng, Xue
    Fu, Jie
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [45] Late complications of radiotherapy for nasopharyngeal carcinoma
    Sumitsawan, Yupa
    Chaiyasate, Saisawat
    Chitapanarux, Imjai
    Anansuthiwara, Marut
    Roongrotwattanasiri, Kannika
    Vaseenon, Vasana
    Tooncam, Hathaikarn
    AURIS NASUS LARYNX, 2009, 36 (02) : 205 - 209
  • [46] Chemotherapy for Nasopharyngeal Carcinoma - Current Recommendation and Controversies
    Sze, Henry
    Blanchard, Pierre
    Ng, Wai Tong
    Pignon, Jean-Pierre
    Lee, Anne W. M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (06) : 1107 - +
  • [47] Radiotherapy for laryngeal squamous cell carcinoma: current standards
    Dirix, Piet
    Lambrecht, Maarten
    Nuyts, Sandra
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (09) : 1461 - 1469
  • [48] Optimization of the margin expanded from the clinical to the planned target volume during intensity-modulated radiotherapy for nasopharyngeal carcinoma
    Wang Fangzheng
    Sun Quanquan
    Jiang Chuner
    Ye Zhimin
    Yang Shuangyan
    Yu Huanhuan
    Shi Jianfang
    Sakamoto, Masoto
    Qin Weifeng
    Fu Zhenfu
    Jiang Yangming
    Wang Yuezhen
    ONCOTARGET, 2017, 8 (66) : 110201 - 110208
  • [49] A prediction model for xerostomia in locoregionally advanced nasopharyngeal carcinoma patients receiving radical radiotherapy
    Li, Minying
    Zhang, Jingjing
    Zha, Yawen
    Li, Yani
    Hu, Bingshuang
    Zheng, Siming
    Zhou, Jiaxiong
    BMC ORAL HEALTH, 2022, 22 (01)
  • [50] Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy
    Lin, Jiabao
    Lv, Xiaofei
    Niu, Meiqi
    Liu, Lizhi
    Chen, Jun
    Xie, Fei
    Zhong, Miao
    Qiu, Shijun
    Li, Li
    Huang, Ruiwang
    NEUROIMAGE-CLINICAL, 2017, 14 : 610 - 621